Literature DB >> 6218099

[Comparison of effect and tolerance of mezlocillin with carbenicillin in the treatment of bacterial infections].

B Tkacz, K Stepka.   

Abstract

Of 60 patients who were suffering from bacterial infections, 30 were treated with mezlocillin and 30 with carbenicillin in a randomized study. The patients received the recommended daily doses of 16 g and 30 g, respectively. Clinical efficacy was found in all patients. Mezlocillin eliminated the strains more reliably than carbenicillin. The bacteriological success rate was 27/30 and 16/30, respectively. We should also take into account the fact that the six patients with cholecystitis who were treated with carbenicillin could not be controlled after treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218099     DOI: 10.1007/bf01640655

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

1.  Azlocillin and mezlocillin, two new alpha-amino-substituted penicillins. A comparison of the in vitro activity with other penicillins.

Authors:  R Wise
Journal:  Arzneimittelforschung       Date:  1979

2.  Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics.

Authors:  D S Reeves; M J Bywater; H A Holt; J M Broughall
Journal:  Arzneimittelforschung       Date:  1979

3.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.